Showing results (261-270 of 338) with videos related to
Sort By:
Pageof 34
Stroke|November 2, 2017
Predictors of Good Outcome After Endovascular Therapy for Vertebrobasilar Occlusion StrokeMehdi Bouslama, Diogo C Haussen, Amin Aghaebrahim, et al.Journal of Neurointerventional Surgery|August 2, 2020
Hyperdense vessel sign as a potential guide for the choice of stent retriever versus contact aspiration as first-line thrombectomy strategyMahmoud H Mohammaden, Diogo C Haussen, Catarina Perry da Camara, et al.Journal of Neurointerventional Surgery|February 17, 2022
Comparative analysis between 1-D, 2-D and 3-D carotid web quantificationCatarina Perry da Camara, Raul G Nogueira, Alhamza R Al-Bayati, et al.Interventional Neurology|June 9, 2020
Body Mass Index and Clinical Outcomes in Large Vessel Occlusion Acute Ischemic Stroke after Endovascular TherapyMehdi Bouslama, Hilarie J Perez, Clara M Barreira, et al.Journal of Neurointerventional Surgery|September 19, 2019
Legal authorized representative experience with smartphone-based electronic informed consent in an acute stroke trialDiogo C Haussen, Leah Craft, Shannon Doppelheuer, et al.European Journal of Neurology|April 23, 2017
Stroke etiology and collaterals: atheroembolic strokes have greater collateral recruitment than cardioembolic strokesL C Rebello, M Bouslama, D C Haussen, et al.Circulation|December 17, 2008
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attackLee H Schwamm, Gregg C Fonarow, Mathew J Reeves, et al.The Journal of Infectious Diseases|April 1, 1996
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomyS M Weiss, P M Roblin, C A Gaydos, et al.Blood|May 26, 1999
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364M S Czuczman, R K Dodge, C C Stewart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancerAnthony W Tolcher, Kim Chi, John Kuhn, et al.Pageof 34